Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Experimental Study Shows that Learned Immunosuppressive Placebo Responses Attenuate Disease Progression in a Rat Model of Arthritis
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
New Evidence Suggests Targeting Neuroinflammation May Be One Key to Slowing Alzheimer’s DiseaseAugust 16, 2016
Microglia and TREM2 Microglia-Specific Gene May Exert a Protective Role in Alzheimer´s DiseaseMay 24, 2016
TLRs-Activated Microglia Polarizes γδ T Cells towards a Neurotoxic IL-17+ γδ T Cell Phenotype: Implications for Multiple Sclerosis, Stroke and Alzheimer´s DiseaseApril 16, 2016
Interleukin-33 Reverses Cognitive Deficits in Alzheimer’s Mouse Model Showing Promise as a Therapeutic TargetApril 27, 2016
Aducanumab Shows Promise and Impressive Effects in Reducing Alzheimer’s Amyloid-β PlaquesOctober 5, 2016
Blocking IL-12 and IL-23 in APPPS1 Mouse Model Shows Promise as an Experimental Therapeutic Approach to Alzheimer’s DiseaseFebruary 13, 2015
Julianne Moore Performing in Alzheimer’s Drama ‘Still Alice’ Wins Hollywood Actress AwardNovember 25, 2014
Tumor Necrosis Factor – a Possible Link Between Age-Related Endocrine Dyscrasia and Alzheimer’s DiseaseOctober 21, 2011
New Evidence that Stress May Increase the Risk of Developing Dementia and Alzheimer’s: the Einstein Aging StudyJanuary 12, 2016
